Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Atherosclerosis|October 1, 2013
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonistRebecca Taub, Edward Chiang, Malorie Chabot-Blanchet, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 8, 2014
Protein tyrosine phosphatase of liver regeneration-1 is required for normal timing of cell cycle progression during liver regenerationYang Jiao, Diana Z Ye, Zhaoyu Li, et al.
The Biochemical Journal|March 29, 2008
Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescenceBogumil Zelent, Stella Odili, Carol Buettger, et al.
Nature Medicine|October 16, 2023
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trialStephen A Harrison, Rebecca Taub, Guy W Neff, et al.
European Journal of Pharmacology|March 22, 2005
Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodentsKenneth W Rohrbach, Songping Han, Jinping Gan, et al.
The Journal of Biological Chemistry|March 6, 2003
Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorptionDong Cheng, Thomas C Nelson, Jian Chen, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2011
Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitorsWeiya Yun, Mushtaq Ahmad, Yingsi Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Receptor occupancy of nonpeptide corticotropin-releasing factor 1 antagonist DMP696: correlation with drug exposure and anxiolytic efficacyYu-Wen Li, Geraldine Hill, Harvey Wong, et al.
Pageof 5